What is Mc3?
MC3 specializes in the creation of bespoke event and training experiences tailored for the pharmaceutical sector. Leveraging over two decades of commitment to the life sciences community, the company focuses on enhancing the efficacy of pharmaceutical teams and ultimately improving patient outcomes. Their comprehensive service offerings encompass event production and customized training solutions designed to ignite performance and cultivate leadership. MC3 employs innovative technologies, notably its Virtuoso platform, to deliver impactful learning journeys and foster robust audience engagement.
How much funding has Mc3 raised?
Mc3 has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Mc3?
The substantial late-stage investment positions Mc3 for accelerated growth, likely focusing on expanding its technological capabilities, particularly its Virtuoso platform, and broadening its market reach within the pharmaceutical and life sciences sectors. This strategic backing will enable Mc3 to further enhance its custom event and training solutions, potentially exploring new hybrid and virtual engagement models. The company's continued dedication to improving pharmaceutical team effectiveness and patient outcomes, coupled with this significant capital infusion, signals a strong future outlook for innovation and market leadership.
See full Mc3 company page
